These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 37293310)

  • 1. Lyme disease and the pursuit of a clinical cure.
    Adkison H; Embers ME
    Front Med (Lausanne); 2023; 10():1183344. PubMed ID: 37293310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update of the Swiss guidelines on post-treatment Lyme disease syndrome.
    Nemeth J; Bernasconi E; Heininger U; Abbas M; Nadal D; Strahm C; Erb S; Zimmerli S; Furrer H; Delaloye J; Kuntzer T; Altpeter E; Sturzenegger M; Weber R; For The Swiss Society For Infectious Diseases And The Swiss Society For Neurology
    Swiss Med Wkly; 2016; 146():w14353. PubMed ID: 27922168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stationary phase persister/biofilm microcolony of Borrelia burgdorferi causes more severe disease in a mouse model of Lyme arthritis: implications for understanding persistence, Post-treatment Lyme Disease Syndrome (PTLDS), and treatment failure.
    Feng J; Li T; Yee R; Yuan Y; Bai C; Cai M; Shi W; Embers M; Brayton C; Saeki H; Gabrielson K; Zhang Y
    Discov Med; 2019 Mar; 27(148):125-138. PubMed ID: 30946803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cimetidine as a novel adjunctive treatment for early stage Lyme disease.
    Shemenski J
    Med Hypotheses; 2019 Jul; 128():94-100. PubMed ID: 27107653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease.
    Weitzner E; McKenna D; Nowakowski J; Scavarda C; Dornbush R; Bittker S; Cooper D; Nadelman RB; Visintainer P; Schwartz I; Wormser GP
    Clin Infect Dis; 2015 Dec; 61(12):1800-6. PubMed ID: 26385994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric Lyme Disease and Vagus Nerve Stimulation.
    Biniaz-Harris N; Kuvaldina M; Fallon BA
    Antibiotics (Basel); 2023 Aug; 12(9):. PubMed ID: 37760644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysautonomia following Lyme disease: a key component of post-treatment Lyme disease syndrome?
    Adler BL; Chung T; Rowe PC; Aucott J
    Front Neurol; 2024; 15():1344862. PubMed ID: 38390594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Borreliella burgdorferi Antimicrobial-Tolerant Persistence in Lyme Disease and Posttreatment Lyme Disease Syndromes.
    Cabello FC; Embers ME; Newman SA; Godfrey HP
    mBio; 2022 Jun; 13(3):e0344021. PubMed ID: 35467428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lyme neuroborreliosis-epidemiology, diagnosis and management.
    Koedel U; Fingerle V; Pfister HW
    Nat Rev Neurol; 2015 Aug; 11(8):446-56. PubMed ID: 26215621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Lyme Disease in the United States and Europe.
    Marques AR; Strle F; Wormser GP
    Emerg Infect Dis; 2021 Aug; 27(8):2017-2024. PubMed ID: 34286689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
    Lebech AM
    APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lyme Neuroborreliosis: Mechanisms of
    Ford L; Tufts DM
    Brain Sci; 2021 Jun; 11(6):. PubMed ID: 34203671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive clinical and laboratory evaluation of 224 patients with persistent symptoms attributed to presumed tick-bite exposure.
    Nilsson K; Skoog E; Jones V; Labbé Sandelin L; Björling C; Fridenström E; Edvinsson M; Mårtensson A; Olsen B
    PLoS One; 2021; 16(3):e0247384. PubMed ID: 33735220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review of Post-treatment Lyme Disease Syndrome and Chronic Lyme Disease for the Practicing Immunologist.
    Wong KH; Shapiro ED; Soffer GK
    Clin Rev Allergy Immunol; 2022 Feb; 62(1):264-271. PubMed ID: 34687445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of delayed growth of the Lyme borreliosis spirochete, Borrelia burgdorferi.
    MacDonald AB; Berger BW; Schwan TG
    Acta Trop; 1990 Dec; 48(2):89-94. PubMed ID: 1980573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent Borrelia burgdorferi
    Verschoor YL; Vrijlandt A; Spijker R; van Hest RM; Ter Hofstede H; van Kempen K; Henningsson AJ; Hovius JW
    Clin Microbiol Rev; 2022 Dec; 35(4):e0007422. PubMed ID: 36222707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium.
    Geebelen L; Lernout T; Kabamba-Mukadi B; Saegeman V; Sprong H; Van Gucht S; Beutels P; Speybroeck N; Tersago K
    Arch Public Health; 2017; 75():42. PubMed ID: 28794875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement Evasion in
    Locke JW
    Antibiotics (Basel); 2019 Jun; 8(2):. PubMed ID: 31200570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients.
    Morrissette M; Pitt N; González A; Strandwitz P; Caboni M; Rebman AW; Knight R; D'Onofrio A; Aucott JN; Soloski MJ; Lewis K
    mBio; 2020 Sep; 11(5):. PubMed ID: 32994327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with lyme disease.
    Stricker RB
    Clin Infect Dis; 2007 Jul; 45(2):149-57. PubMed ID: 17578772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.